These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35192870)

  • 1. Effect of Oat (Avena sativa L.) Consumption on Lipid Profile With Focus on Triglycerides and High-density Lipoprotein Cholesterol (HDL-C): An Updated Systematic Review.
    Amerizadeh A; Ghaheh HS; Vaseghi G; Farajzadegan Z; Asgary S
    Curr Probl Cardiol; 2023 Jul; 48(7):101153. PubMed ID: 35192870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Oat Beta-Glucan Intake on Lipid Profiles in Hypercholesterolemic Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Yu J; Xia J; Yang C; Pan D; Xu D; Sun G; Xia H
    Nutrients; 2022 May; 14(10):. PubMed ID: 35631184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia.
    Reyna-Villasmil N; Bermúdez-Pirela V; Mengual-Moreno E; Arias N; Cano-Ponce C; Leal-Gonzalez E; Souki A; Inglett GE; Israili ZH; Hernández-Hernández R; Valasco M; Arraiz N
    Am J Ther; 2007; 14(2):203-12. PubMed ID: 17414591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials.
    Ho HV; Sievenpiper JL; Zurbau A; Blanco Mejia S; Jovanovski E; Au-Yeung F; Jenkins AL; Vuksan V
    Br J Nutr; 2016 Oct; 116(8):1369-1382. PubMed ID: 27724985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol-lowering effects of oat β-glucan: a meta-analysis of randomized controlled trials.
    Whitehead A; Beck EJ; Tosh S; Wolever TM
    Am J Clin Nutr; 2014 Dec; 100(6):1413-21. PubMed ID: 25411276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oat consumption on lipid profiles in hypercholesterolemic adults.
    Thongoun P; Pavadhgul P; Bumrungpert A; Satitvipawee P; Harjani Y; Kurilich A
    J Med Assoc Thai; 2013 Dec; 96 Suppl 5():S25-32. PubMed ID: 24851570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipids and postprandial glucose and insulin levels in hyperlipidemic subjects after consumption of an oat beta-glucan-containing ready meal.
    Biörklund M; Holm J; Onning G
    Ann Nutr Metab; 2008; 52(2):83-90. PubMed ID: 18334815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-grain ready-to-eat oat cereal, as part of a dietary program for weight loss, reduces low-density lipoprotein cholesterol in adults with overweight and obesity more than a dietary program including low-fiber control foods.
    Maki KC; Beiseigel JM; Jonnalagadda SS; Gugger CK; Reeves MS; Farmer MV; Kaden VN; Rains TM
    J Am Diet Assoc; 2010 Feb; 110(2):205-14. PubMed ID: 20102847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of the effects of beta-glucan consumption on serum lipid profile and glucose level in hypercholesterolemic subjects.
    Zhu X; Sun X; Wang M; Zhang C; Cao Y; Mo G; Liang J; Zhu S
    Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):714-23. PubMed ID: 26026211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial.
    Queenan KM; Stewart ML; Smith KN; Thomas W; Fulcher RG; Slavin JL
    Nutr J; 2007 Mar; 6():6. PubMed ID: 17386092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracted oat and barley β-glucans do not affect cholesterol metabolism in young healthy adults.
    Ibrügger S; Kristensen M; Poulsen MW; Mikkelsen MS; Ejsing J; Jespersen BM; Dragsted LO; Engelsen SB; Bügel S
    J Nutr; 2013 Oct; 143(10):1579-85. PubMed ID: 23946347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of beta-glucan level in oat fiber extracts on blood lipids in men and women.
    Behall KM; Scholfield DJ; Hallfrisch J
    J Am Coll Nutr; 1997 Feb; 16(1):46-51. PubMed ID: 9013433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol-lowering benefits of oat-containing cereal in Hispanic americans.
    Karmally W; Montez MG; Palmas W; Martinez W; Branstetter A; Ramakrishnan R; Holleran SF; Haffner SM; Ginsberg HN
    J Am Diet Assoc; 2005 Jun; 105(6):967-70. PubMed ID: 15942550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and Long-Term Effects of Wholegrain Oat Intake on Weight Management and Glucolipid Metabolism in Overweight Type-2 Diabetics: A Randomized Control Trial.
    Li X; Cai X; Ma X; Jing L; Gu J; Bao L; Li J; Xu M; Zhang Z; Li Y
    Nutrients; 2016 Sep; 8(9):. PubMed ID: 27618090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of the effect of β-glucan intake on blood cholesterol and glucose levels.
    Tiwari U; Cummins E
    Nutrition; 2011 Oct; 27(10):1008-16. PubMed ID: 21470820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-fiber oat cereal compared with wheat cereal consumption favorably alters LDL-cholesterol subclass and particle numbers in middle-aged and older men.
    Davy BM; Davy KP; Ho RC; Beske SD; Davrath LR; Melby CL
    Am J Clin Nutr; 2002 Aug; 76(2):351-8. PubMed ID: 12145006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oat beta-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects.
    Braaten JT; Wood PJ; Scott FW; Wolynetz MS; Lowe MK; Bradley-White P; Collins MW
    Eur J Clin Nutr; 1994 Jul; 48(7):465-74. PubMed ID: 7956987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical properties of oat β-glucan influence its ability to reduce serum LDL cholesterol in humans: a randomized clinical trial.
    Wolever TM; Tosh SM; Gibbs AL; Brand-Miller J; Duncan AM; Hart V; Lamarche B; Thomson BA; Duss R; Wood PJ
    Am J Clin Nutr; 2010 Oct; 92(4):723-32. PubMed ID: 20660224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous intake of oat bran and atorvastatin reduces their efficacy to lower lipid levels and atherosclerosis in LDLr-/- mice.
    Eussen SR; Rompelberg CJ; Andersson KE; Klungel OH; Hellstrand P; Oste R; van Kranen H; Garssen J
    Pharmacol Res; 2011 Jul; 64(1):36-43. PubMed ID: 21371558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.